Patent intelligence · US
US 8680319
Method for producing antifolate agents having glutamic acid part in their structure
Method for producing antifolate agents having glutamic acid part in their structure
Patent details — US 8680319
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 25, 2014
- Expiration
- Mar 20, 2034
- Applicant
- Kocak Farma Ilac ve Kimya Sanayi A.S.
- Claims
- 15
- CPC classes
- A61P, A61P35/00
Quick answer
US 8680319 (Method for producing antifolate agents having glutamic acid part in their structure) is held by Kocak Farma Ilac ve Kimya Sanayi A.S.. Status: granted. Granted Mar 25, 2014. Expires Mar 20, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Kocak Farma Ilac ve Kimya Sanayi A.S.
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61P, A61P35/00
More from Kocak Farma Ilac ve Kimya Sanayi A.S.
Related pharmaceutical patents in our USPTO index.
-
US 12427199
Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments
granted -
US 12409213
Live attenuated oral vaccine against shigellosis and typhoid fever
granted -
US 12246059
Stable hybrid FC fusion G-CSF formulation
granted -
US 12171822
Infectious plasmodium sporozoites grown in vitro
granted -
US 12156870
Antibody drug conjugates comprising sting agonists
granted -
US 12129288
Polynucleotides heterodimers of soluble interferon receptors and uses thereof
granted -
US 12077543
P2X3 and/or P2X2/3 compounds and methods
granted -
US 11987628
Methods and compositions for modulating CAR-T activity
granted
Frequently asked questions
What is US patent 8680319?
US 8680319 (Method for producing antifolate agents having glutamic acid part in their structure) is held by Kocak Farma Ilac ve Kimya Sanayi A.S.. Status: granted. Granted Mar 25, 2014. Expires Mar 20, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8680319?
Kocak Farma Ilac ve Kimya Sanayi A.S. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 136 pharmaceutical patents for this assignee.
When does US 8680319 expire?
Our index shows an expiration date of Mar 20, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.